Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
GS-9876, a Novel, Highly Selective, SYK Inhibitor in Patients with Active Rheumatoid Arthritis: Safety, Tolerability and Efficacy Results of a Phase 2 Study Kivitz, A. J., Mehta, D. P., Matzkies, F., Mozaffarian, A., Kunder, R., Di Paolo, J., Mozaffarian, N., Hsueh, S., Kim, J., Jiang, W., Liu, L., Sundy, J. S., Genovese, M. C. WILEY. 2018
View details for Web of Science ID 000447268904251